Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 90 Results

November 5, 2021

Surrozen to Present at The Stifel 2021 Virtual Healthcare Conference

October 5, 2021

Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week

September 23, 2021

Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources

August 11, 2021

Surrozen Debuts as Publicly Traded Leader in Wnt Biology and Tissue Regeneration

August 5, 2021

Surrozen to Present at Canaccord Genuity’s 41st Annual Growth Conference

July 9, 2021

Surrozen Presents New Data Demonstrating Superior Activity of SZN-1326 in Preclinical Inflammatory Bowel Disease Models at 16th Congress of the European Crohn’s and Colitis Organisation (ECCO)

June 25, 2021

Surrozen Presents Data at 2021 International Liver Conference for Wnt-Modulating Antibody SZN-043

June 17, 2021

Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Biology Conference: Fundamental Mechanisms and Translational Applications

June 1, 2021

Surrozen Publishes Article in Nature Communications Demonstrating Selective Wnt Mimetics Stimulate Bone Mass Accrual in Disease Models of Osteoporosis,Aging and Long-Bone Fracture

May 24, 2021

Surrozen Presents Data from Lead Wnt-Modulating Antibody Programs, SZN-1326 and SZN-043,in Six Oral and Poster Presentations at 2021 Digestive Disease Week Conference

«...5 678 9 »

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

Privacy Policy
FCOI Policy
Accessibility

Scroll to Top